Anika Therapeutics (ANIK) Competitors $13.83 -0.86 (-5.85%) As of 01:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIK vs. CERS, OSUR, UTMD, COO, WST, ALGN, MMSI, ICUI, HAE, and XRAYShould you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Anika Therapeutics vs. Cerus OraSure Technologies Utah Medical Products Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA Anika Therapeutics (NASDAQ:ANIK) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations. Does the media refer more to ANIK or CERS? In the previous week, Anika Therapeutics and Anika Therapeutics both had 1 articles in the media. Anika Therapeutics' average media sentiment score of 0.00 beat Cerus' score of -0.71 indicating that Anika Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anika Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cerus 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Is ANIK or CERS more profitable? Cerus has a net margin of -11.60% compared to Anika Therapeutics' net margin of -59.40%. Anika Therapeutics' return on equity of -2.22% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Anika Therapeutics-59.40% -2.22% -1.75% Cerus -11.60%-40.55%-11.12% Does the MarketBeat Community believe in ANIK or CERS? Cerus received 265 more outperform votes than Anika Therapeutics when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 64.48% of users gave Anika Therapeutics an outperform vote. CompanyUnderperformOutperformAnika TherapeuticsOutperform Votes30564.48% Underperform Votes16835.52% CerusOutperform Votes57072.34% Underperform Votes21827.66% Which has higher valuation and earnings, ANIK or CERS? Cerus has higher revenue and earnings than Anika Therapeutics. Cerus is trading at a lower price-to-earnings ratio than Anika Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnika Therapeutics$119.91M1.64-$82.67M-$3.85-3.59Cerus$180.27M1.25-$37.49M-$0.11-11.05 Do analysts recommend ANIK or CERS? Anika Therapeutics currently has a consensus price target of $22.00, indicating a potential upside of 59.07%. Cerus has a consensus price target of $4.00, indicating a potential upside of 229.22%. Given Cerus' stronger consensus rating and higher probable upside, analysts plainly believe Cerus is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anika Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Cerus 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in ANIK or CERS? 91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 7.9% of Anika Therapeutics shares are held by insiders. Comparatively, 3.4% of Cerus shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility & risk, ANIK or CERS? Anika Therapeutics has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500. SummaryCerus beats Anika Therapeutics on 10 of the 17 factors compared between the two stocks. Remove Ads Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIK vs. The Competition Export to ExcelMetricAnika TherapeuticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$196.05M$4.04B$5.33B$7.13BDividend YieldN/A37.84%4.87%4.05%P/E Ratio-2.0827.4222.8917.40Price / Sales1.6444.99357.5184.53Price / Cash3.5351.0838.1634.64Price / Book0.955.666.253.79Net Income-$82.67M$67.64M$3.21B$247.10M7 Day Performance-8.47%-9.30%-8.04%-7.61%1 Month Performance-17.97%-8.96%-2.99%-10.32%1 Year Performance-46.83%4.84%3.54%-7.75% Anika Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIKAnika Therapeutics3.08 of 5 stars$13.83-5.9%$22.00+59.1%-44.1%$196.05M$119.91M-2.08300Gap DownCERSCerus1.7764 of 5 stars$1.39-2.1%$4.00+187.8%-31.4%$258.25M$180.27M-12.64290Gap DownOSUROraSure Technologies4.7091 of 5 stars$3.37-1.7%$5.50+63.2%-47.9%$252.08M$185.83M22.47840News CoveragePositive NewsGap DownUTMDUtah Medical Products2.793 of 5 stars$56.04-0.2%N/A-19.8%$183.92M$40.90M14.19180News CoveragePositive NewsCOOCooper Companies3.214 of 5 stars$84.35+0.7%$110.25+30.7%-21.0%$16.87B$3.93B43.2616,000Short Interest ↑WSTWest Pharmaceutical Services4.5018 of 5 stars$223.95+0.8%$332.50+48.5%-43.2%$16.19B$2.89B33.4710,700Positive NewsALGNAlign Technology4.4794 of 5 stars$158.86-0.2%$262.64+65.3%-50.3%$11.69B$4.00B28.3221,610Gap DownMMSIMerit Medical Systems4.1146 of 5 stars$105.71+1.7%$111.70+5.7%+42.7%$6.22B$1.36B51.826,950Positive NewsGap DownHigh Trading VolumeICUIICU Medical4.0441 of 5 stars$138.86-0.9%$168.67+21.5%+37.0%$3.40B$2.38B-30.3914,500Analyst UpgradeNews CoveragePositive NewsHAEHaemonetics4.5919 of 5 stars$63.65+0.7%$101.22+59.0%-26.0%$3.20B$1.37B25.062,820Positive NewsXRAYDENTSPLY SIRONA4.9149 of 5 stars$14.94+0.1%$23.33+56.2%-57.2%$2.97B$3.79B-7.2215,000Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives Cooper Companies Alternatives West Pharmaceutical Services Alternatives Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives Haemonetics Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANIK) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANIK Stock Free ANIK Stock Alerts